Q4 2019 Holdings
Filed 2020-02-14 | 52 holdings | $88.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-04-09) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | $140 | 38,340 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $187 | 11,500 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $699 | 63,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $968 | 50,500 | 0.0% |
| Invesco Curncyshs Brit PND S(FXB) | BRIT POUN STRL | 46138M109 | $1.5K | 11,600 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.9K | 275,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $2.1K | 462,500 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $2.1K | 425,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $2.2K | 40,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $2.7K | 33,400 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $2.7K | 1,150,000 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $2.8K | 450,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $3.1K | 224,359 | 0.0% |
| Apellis Pharmaceuticals IncPut | COM | 03753U956 | $3.8K | 300,000 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $3.8K | 235,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $3.9K | 350,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $4.6K | 800,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.8K | 200,000 | 0.0% |
| Invesco Curncyshs Swiss Fran(FXF) | SWISS FRANC | 46138R108 | $4.9K | 52,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $5.1K | 1,200,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $5.4K | 175,000 | 0.0% |
| Amarin Corp PLCCallA | SPONS ADR NEW | 023111206 | $5.4K | 250,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $5.4K | 275,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $6.0K | 300,000 | 0.0% |
| Amarin Corp PLCCall | SPONS ADR NEW | 023111906 | $6.3K | 250,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $6.4K | 750,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $7.0K | 450,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $7.4K | 415,000 | 0.0% |
| Apellis Pharmaceuticals IncCall | COM | 03753U906 | $7.5K | 250,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS)CallA | COM | 03753U106 | $7.7K | 250,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $7.9K | 400,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $8.0K | 750,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $8.4K | 65,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS)PutA | COM | 03753U106 | $9.2K | 300,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA)CallA | COM | 462260100 | $9.7K | 350,000 | 0.0% |
| Iovance Biotherapeutics IncCall | COM | 462260900 | $10.5K | 350,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $10.6K | 500,000 | 0.0% |
| Sage Therapeutics Inc(SG7)CallA | COM | 78667J108 | $10.8K | 150,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $12.0K | 150,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $12.2K | 1,250,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $12.7K | 800,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $13.5K | 1,175,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $13.9K | 575,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $15.3K | 75,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $15.9K | 700,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $18.0K | 650,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $19.3K | 150,000 | 0.0% |
| Sage Therapeutics IncCall | COM | 78667J908 | $22.5K | 150,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $27.1K | 575,500 | 0.0% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $45.7K | 500,000 | 0.1% |